Endometrial cancer and the IGF system: A case-control study in Greece

被引:57
作者
Petridou, E
Koukoulomatis, P
Alexe, DM
Voulgaris, Z
Spanos, E
Trichopoulos, D
机构
[1] Univ Athens, Sch Med, Dept Hyg & Epidemiol, GR-11527 Athens, Greece
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[3] Univ Athens, Sch Med, Dept Obstet & Gynecol 1, GR-11527 Athens, Greece
[4] BIOMED Int Diagnost Ctr, Athens, Greece
关键词
endometrial cancer; IGF factors; obesity;
D O I
10.1159/000070291
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Insulin-like growth factor I (IGF-I) and other components of the IGF system have been implicated in the etiology of several human malignancies. We have undertaken a case-control study among Greek women to explore the relation of major components of the IGF system (IGF-I, IGF-II and IGF-binding protein 3, IGFBP-3) with endometrial cancer risk. Methods: During a 1-year period (1999), 84 incident cases of histologically confirmed endometrial cancer were compared with 84 control women admitted to the same clinical department for small gynecological operations, mainly pelvic prolapse. Data were modeled through multiple logistic regression. Results: Endometrial cancer was positively associated with IGF-II and inversely with IGF-I. Both associations were statistically significant and they appear symmetrical around the null value. IGFBP-3 is positively associated with endometrial cancer risk, but this association does not reach statistical significance. Conclusions: This study adds to the gradually developing consensus that components of the IGF system play a central role in human carcinogenesis. It is possible that IGF-II, rather than IGF-I, is closely linked to the etiology of endometrial cancer, the form of cancer most strongly associated with obesity.
引用
收藏
页码:341 / 345
页数:5
相关论文
共 24 条
[1]   Increased circulating levels of insulin-like growth factor-I and decreased circulating levels of insulin-like growth factor binding protein-1 in postmenopausal women with endometrial cancer [J].
Ayabe, T ;
Tsutsumi, O ;
Sakai, H ;
Yoshikawa, H ;
Yano, T ;
Kurimoto, F ;
Taketani, Y .
ENDOCRINE JOURNAL, 1997, 44 (03) :419-424
[2]  
Bermont L, 2000, CELL MOL BIOL, V46, P1173
[3]   Relationship between postmenopausal hormone replacement therapy and ovarian cancer [J].
Bosetti, C ;
Negri, E ;
Franceschi, S ;
Trichopoulos, D ;
Beral, V ;
La Vecchia, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (24) :3089-3089
[4]   Serum insulin-like growth factor-I levels and prostate cancer risk - Interpreting the evidence [J].
Cohen, P .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (12) :876-879
[5]   Insulin-like growth factor-1 and binding protein-3 and risk of cancer [J].
Giovannucci, E .
HORMONE RESEARCH, 1999, 51 :34-41
[6]   Circulating concentrations of insulin-like growth factor-I and risk of breast cancer [J].
Hankinson, SE ;
Willett, WC ;
Colditz, GA ;
Hunter, DJ ;
Michaud, DS ;
Deroo, B ;
Rosner, B ;
Speizer, FE ;
Pollak, M .
LANCET, 1998, 351 (9113) :1393-1396
[7]  
LAVECCHIA C, 1984, J NATL CANCER I, V73, P667
[8]  
Manousos O, 1999, INT J CANCER, V83, P15, DOI 10.1002/(SICI)1097-0215(19990924)83:1<15::AID-IJC4>3.0.CO
[9]  
2-Y
[10]   Cervical epidermal growth factor-receptor (EGF-R) and serum insulin-like growth factor II (IGF-II) levels are potential markers for cervical cancer [J].
Mathur, SP ;
Mathur, RS ;
Young, RC .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2000, 44 (04) :222-230